HRS4R
Vull donar

JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS

Firma
JOSÉ MANUEL FERNÁNDEZ-REAL-LEMOS
Posició
Cap de Grup - R4
Caps de Grup - R4
curriculum

Projectes

Codi oficial: SOPHIA Data inici: 09/07/2020 Data fi: 08/07/2025 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: EUROPEAN COMISSION Ajuda: 300,000 €
Codi oficial: FI19/00293 Data inici: 01/01/2020 Data fi: 31/12/2023 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 82,400 €
Codi oficial: CD20/00051 Data inici: 01/01/2021 Data fi: 17/06/2024 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 80,598 €
Codi oficial: SMARTAGE Data inici: 01/09/2020 Data fi: 31/08/2024 Investigador/a principal: JORDI MAYNERIS PERXACHS, JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: EUROPEAN COMISSION Ajuda: 417,569.76 €
Codi oficial: 19/0006059 Data inici: 03/02/2020 Data fi: 02/02/2024 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: DIABETES UK Ajuda: 0 €
Codi oficial: METASUCC Data inici: 01/12/2020 Data fi: 31/12/2024 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: FUND. BANCARIA "LA CAIXA" Ajuda: 258,752.50 €
Codi oficial: SLT017/20/000164 Data inici: 12/07/2021 Data fi: 31/12/2024 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: GENERALITAT DE CATALUNYA Ajuda: 92,623.53 €
Codi oficial: PI21/01361 Data inici: 01/01/2022 Data fi: 31/12/2024 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 304,920 €
Codi oficial: PMP21/00072 Data inici: 01/01/2022 Data fi: 31/12/2025 Investigador/a principal: JORDI MAYNERIS PERXACHS, JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 141,185 €
Codi oficial: HR22-00737 Data inici: 01/10/2022 Data fi: 30/09/2025 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: FUND. BANCARIA "LA CAIXA" Ajuda: 374,894.76 €
Codi oficial: INT22/00015 Data inici: 01/01/2023 Data fi: 31/12/2024 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 60,000 €
Codi oficial: 2021 SGR 01263 Data inici: 01/01/2022 Data fi: 31/12/2024 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: AGENCIA DE GESTIO D'AJUTS UNIV. I RECER. Ajuda: 60,000 €
Codi oficial: RED2022-134313-T Data inici: 01/06/2023 Data fi: 31/05/2025 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: MINISTERIO DE ECONOMIA Y COMPETITIVIDAD MINECO / Ajuda: 0 €
Codi oficial: SLT028/23/000133 Data inici: 01/08/2023 Data fi: 31/12/2025 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: GENERALITAT DE CATALUNYA Ajuda: 75,784.93 €

Publicacions

Milbank E, Díaz-Trelles R, Dragano N, Latorre J, Mukthavaram R, Mayneris-Perxachs J, Ortega F, Federici M, Burcelin R, Karmali PP, Tachikawa K, Chivukula P, López M, Fernández-Real JM, Moreno-Navarrete JM

Liver lipopolysaccharide binding protein prevents hepatic inflammation in physiological and pathological non-obesogenic conditions

PHARMACOLOGICAL RESEARCH, 2023, 187, 106562-106562 dx.doi.org/10.1016/j.phrs.2022.106562
Champion C, Neagoe RM, Effernberger M, Sala DT, Servant F, Christensen JE, Arnoriaga-Rodriguez M, Amar J, Lelouvier B, Loubieres P, Azalbert V, Minty M, Thomas C, Blasco-Baque V, Gamboa F, Tilg H, Cardellini M, Federici M, Fernández-Real JM, Loubes JM, Burcelin R

Human liver microbiota modeling strategy at the early onset of fibrosis.

BMC MICROBIOLOGY, 2023, 23, 34-34 dx.doi.org/10.1186/s12866-023-02774-4
Hinojosa-Moscoso A, Motger-Albertí A, De la Calle-Vargas E, Martí-Navas M, Biarnés C, Arnoriaga-Rodríguez M, Blasco G, Puig J, Luque-Córdoba D, Priego-Capote F, Moreno-Navarrete JM, Fernández-Real JM

The Longitudinal Changes in Subcutaneous Abdominal Tissue and Visceral Adipose Tissue Volumetries Are Associated with Iron Status.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 dx.doi.org/10.3390/ijms24054750
González-Moro I, Rojas-Márquez H, Sebastian-delaCruz M, Mentxaka-Salgado J, Olazagoitia-Garmendia A, Mendoza LM, Lluch A, Fantuzzi F, Lambert C, Ares Blanco J, Marselli L, Marchetti P, Cnop M, Delgado E, Fernández-Real JM, Ortega FJ, Castellanos-Rubio A, Santin I

A long non-coding RNA that harbors a SNP associated with type 2 diabetes regulates the expression of TGM2 gene in pancreatic beta cells.

Frontiers in Endocrinology, 2023, 14, 1101934-1101934 dx.doi.org/10.3389/fendo.2023.1101934
Valenti L, Corradini E, Adams LA, Aigner E, Alqahtani S, Arrese M, Bardou-Jacquet E, Bugianesi E, Fernandez-Real JM, Girelli D, Hagström H, Henninger B, Kowdley K, Ligabue G, McClain D, Lainé F, Miyanishi K, Muckenthaler MU, Pagani A, Pedrotti P, Pietrangelo A, Prati D, Ryan JD, Silvestri L, Spearman CW, Stål P, Tsochatzis EA, Vinchi F, Zheng MH, Zoller H

Consensus Statement on the definition and classification of metabolic hyperferritinaemia.

NATURE REVIEWS ENDOCRINOLOGY, 2023, 19, 1-12 dx.doi.org/10.1038/s41574-023-00807-6
Sol J, Obis È, Mota-Martorell N, Pradas I, Galo-Licona JD, Martin-Garí M, Fernández-Bernal A, Ortega-Bravo M, Mayneris-Perxachs J, Borrás C, Viña J, de la Fuente M, Mate I, Biarnes C, Pedraza S, Vilanova JC, Brugada R, Ramos R, Serena J, Ramió-Torrentà L, Pineda V, Daunis-I-Estadella P, Thió-Henestrosa S, Barretina J, Garre-Olmo J, Portero-Otin M, Fernández-Real JM, Puig J, Jové M, Pamplona R

Plasma acylcarnitines and gut-derived aromatic amino acids as sex-specific hub metabolites of the human aging metabolome.

Aging Cell, 2023, 22 dx.doi.org/10.1111/acel.13821
Mayneris-Perxachs J, Fernández-Real JM

Proline-related metabolites: Towards biological diagnosis of depression.

PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2023, 77, 195-195 dx.doi.org/10.1111/pcn.13535
Villanueva-Carmona T, Cedó L, Madeira A, Ceperuelo-Mallafré V, Rodríguez-Peña MM, Núñez-Roa C, Maymó-Masip E, Repollés-de-Dalmau M, Badia J, Keiran N, Mirasierra M, Pimenta-Lopes C, Sabadell-Basallote J, Bosch R, Caubet L, Escolà-Gil JC, Fernández-Real JM, Vilarrasa N, Ventura F, Vallejo M, Vendrell J, Fernández-Veledo S

SUCNR1 signaling in adipocytes controls energy metabolism by modulating circadian clock and leptin expression.

CELL METABOLISM, 2023, 35 dx.doi.org/10.1016/j.cmet.2023.03.004
Arnoriaga-Rodríguez M, Leal Y, Mayneris-Perxachs J, Pérez-Brocal V, Moya A, Ricart W, Fernández-Balsells M, Fernández-Real JM

Gut microbiota composition and functionality are associated with REM sleep duration and continuous glucose levels.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108, 2931-2939 dx.doi.org/10.1210/clinem/dgad258
Amin A, Badenes M, Tüshaus J, de Carvalho É, Burbridge E, Faísca P, Trávnícková K, Barros A, Carobbio S, Domingos PM, Vidal-Puig A, Moita LF, Maguire S, Stríšovský K, Ortega FJ, Fernández-Real JM, Lichtenthaler SF, Adrain C

Semaphorin 4B is an ADAM17-cleaved adipokine that inhibits adipocyte differentiation and thermogenesis.

Molecular Metabolism, 2023, 73, 101731-101731 dx.doi.org/10.1016/j.molmet.2023.101731

Propietat intel·lectual

José Manuel Fernández-real Lemos

METHOD FOR DIAGNOSING HEPATIC FIBROSIS

Número de publicació: WO2015162200 Data de publicació: 2015-10-29

José Manuel Fernández-real Lemos

METHOD FOR DIAGNOSING HEPATIC FIBROSIS BASED ON BACTERIAL PROFILE AND DIVERSITY

Número de publicació: WO2017060039 Data de publicació: 2018-08-15

José Manuel Fernández-real Lemos

METHODS FOR DETERMINING WHETHER A SUBJECT HAS OR IS AT RISK OF HAVING A NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) OR ONE OF ITS COMPLICATIONS

Número de publicació: WO2019077125 Data de publicació: 2019-04-25

Formulari de contacte

Coneix l’IDIBGI!

menu